Nektar Therapeutics | Créances Commerciales



Trade Debtors Changement Date
Agios Pharmaceuticals USD 3.34M 765K 2025-03
ALKERMES USD 321.75M 72.97M 2025-03
Amgen USD 8.13B 1.35B 2025-03
Baxter International USD 1.73B 53M 2024-12
Biogen USD 2B 127.7M 2025-03
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Cipla INR 55.22B 657.5M 2025-03
Dr.Reddys Laboratories INR 90.42B 4.91B 2025-03
Eisai JPY 220.02B 15.62B 2025-03
Eli Lilly USD 14B 727.8M 2025-03
Exelixis USD 281.64M 16.2M 2025-04
Gilead Sciences USD 4.39B 32M 2025-03
GlaxoSmithKline GBP 7.5B 176M 2025-03
Grifols EUR 871.58M 135.79M 2024-12
Halozyme Therapeutics USD 304.62M 3.83M 2025-03
Incyte USD 823.13M 30.02M 2025-03
Ionis Pharmaceuticals USD 39.71M 52.48M 2025-03
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
MacroGenics USD 4.31M 4.44M 2024-12
Merck USD 11.57B 452M 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 9B 854M 2024-12
Pfizer USD 14.74B 32M 2025-03
Roche Holding CHF 13.46B 984M 2024-12
Sarepta Therapeutics USD 724.52M 74.8M 2025-03
Takeda JPY 725.25B 9.81B 2025-03
Teva Pharmaceutical Industries USD 3.38B 325M 2025-03
Xencor USD 37.78M 23.06M 2025-03



Nektar Therapeutics Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.